Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients

Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients

Leigh MacConell,1 Kate Gurney,2 Jaret Malloy,1 Ming Zhou,3 Orville Kolterman4 1Clinical Development, Bristol-Myers Squibb, San Diego, CA, USA; 2Medical Writing, Bristol-Myers Squibb, San Diego, CA, USA; 3Biostatistics, Bristol-Myers Squibb, Princeton, NJ, 4Safety, Bristol-Myers Squibb, San Diego, CA...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: MacConell L, Gurney K, Malloy J, Zhou M, Kolterman O
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Specialties of internal medicine
RC581-951
Acceso en línea:https://doaj.org/article/eef3036ef72f411aa398b6c9392b9ef7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares